Short Interest in Daxor Co. (NASDAQ:DXR) Grows By 15.2%

Daxor Co. (NASDAQ:DXR) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 7,600 shares, a growth of 15.2% from the May 31st total of 6,600 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average daily volume of 2,100 shares, the short-interest ratio is presently 3.6 days.

Daxor Trading Down 2.8 %

DXR opened at $9.32 on Monday. Daxor has a 52-week low of $7.11 and a 52-week high of $10.15. The company has a 50 day moving average of $9.35 and a two-hundred day moving average of $8.98.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.